GlassScriptPhysician profile
Mitchell S Pearce
NPI 1932875598
$2,902.86
in general payments reported to CMS, 2019-2025
38 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $1,217 · 2023: $1,173 · 2024: $274 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,556.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $585.58 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $338.09 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $208.85 | 2021-2023 | Farxiga, Breztri |
| Corium, LLC | $150.71 | 2022-2023 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.37 | 2021-2023 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $112.25 | 2021-2023 | Trintellix |
| Neos Therapeutics, LP | $99.22 | 2021-2023 | Adzenys Xr-Odt |
| Lilly USA, LLC | $93.30 | 2022-2024 | Mounjaro, Zepbound |
| Paratek Pharmaceuticals, INC. | $88.52 | 2024-2025 | Nuzyra |
| Axsome Therapeutics, INC. | $85.84 | 2023 | Auvelity |
| Glaxosmithkline, LLC. | $85.46 | 2022-2023 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $73.44 | 2023 | |
| Pfizer INC. | $55.62 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $55.06 | 2022 | |
| Tris Pharma INC | $53.88 | 2022-2023 | Dyanavel Xr |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $50.41 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $50.26 | 2023 | Dexcom G6 Transmitter |
| Impel Pharmaceuticals INC. | $43.91 | 2023 | Trudhesa |
| Ironshore Pharmaceuticals INC. | $42.33 | 2022 | |
| Noven Therapeutics, LLC | $39.54 | 2023 | Xelstrym |
| Kowa Pharmaceuticals America, INC. | $39.00 | 2022 | |
| Idorsia Pharmaceuticals US INC | $36.45 | 2023 | Quviviq |
| Amarin Pharma, INC. | $35.64 | 2021 | |
| Amgen INC. | $34.83 | 2022-2024 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.34 | 2022-2023 | Jardiance, Synjardy, Tradjenta |
| Alexion Pharmaceuticals, INC. | $32.77 | 2022-2023 | Strensiq |
| Kerecis Limited | $27.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Hartmann USA, INC. | $24.73 | 2025 | Zetuvit Plus 10x10 P10 |
| Saluda Medical Americas, INC. | $24.13 | 2024 | Evoke |
| Daiichi Sankyo INC. | $21.68 | 2022 | |
| Royal Biologics, INC. | $21.55 | 2024 | |
| Medtronic, INC. | $19.23 | 2024 | Interstim |
| Sanofi Pasteur INC. | $18.95 | 2022 | |
| Viiv Healthcare Company | $17.98 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $17.29 | 2023 | Rexulti |
| Astellas Pharma US INC | $13.94 | 2023 | Veozah |
| Reprise Biomedical, INC. | $13.65 | 2024 | Miro3d |
| Advanced Oxygen Therapy INC. | $10.93 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Pearce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.